Senior researcher Dr Ali Ahmed (University of Alabama, Birmingham) told heartwire that the differing conclusions are the result of two different methodologies used to analyze the data. He said their ...

Foxglove, a flowering plant long feared for its toxicity, became an unlikely source of a widely studied heart drug. Digoxin, a cardiac glycoside associated in modern medicine with Digitalis species ...

Findings from the current study demonstrate that over half of chronic HF patients in the DIG trial had severe and more advanced disease as evidenced by the presence of NYHA III–IV symptoms, LVEF <25%, ...

A strong, rhythmic pulse is a lifelong companion for those with a healthy heart. But for about 1% of babies born in the U.S. every year, developmental heart problems compromise that steady beat. One ...

NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...

Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test. HealthDay News — For patients with atrial fibrillation, digoxin ...

A proof-of-concept trial by researchers at ETH Zurich, the University Hospitals of Basel and Zurich, and the Basel-Land Cantonal Hospital, demonstrated that treating breast cancer patients with a low, ...